Ten whistleblower cases were filed against biotechnology giant Amgen, accusing the company of off-label marketing, kickbacks, price-gouging, and putting patient health at risk.

FCA | Amgen, off-label marketing, Aranesp

Does Caronia change everything, nothing, or not very much?

FCA | Caronia, free speech, off-label marketing, Orphan, Jazz, second circuit

GlaxoSmithKline: $3 Billion Settlement and a Big Wink

FCA | GSK, off-label marketing, pharmaceutical, criminal, civil